Urecholine (Bethanecol)

Do’s

• Take Urecholine by mouth on an empty stomach (1 hour before or 2 hours after meals) as directed by your healthcare provider. The usual frequency of administration is 3 to 4 times daily.
• Taking Urecholine on an empty stomach may help reduce the risk of nausea or vomiting associated with the medication.
• The dosage of Urecholine is based on your medical condition and your response to treatment. Follow your healthcare provider’s instructions regarding the appropriate dosage for your specific situation.
• Use Urecholine regularly to derive the most benefit from it. Take it at the same times each day to help you remember.
• Keep your healthcare provider informed about the duration and progression of your condition while using Urecholine. If your condition persists or worsens, consult your healthcare provider for further guidance and assessment.

Common Side Effects:

• An urgent need to urinate
• Burping and increased saliva
• Headache and dizziness
• Sweating, flushing, and a general ill feeling
• Watery eyes and vision changes

Serious Side Effects:

• Signs of allergic reaction, such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat
• Slow heartbeats, lightheadedness, wheezing, chest tightness, or trouble breathing 

Seek emergency medical help if you experience signs of an allergic reaction and call your healthcare provider immediately if you encounter any of the other serious symptoms listed.

This is not an exhaustive list of potential side effects. If you notice any other effects not listed above, contact your healthcare provider for further guidance and evaluation.

Urecholine should only be used as directed by a healthcare provider. Follow the specific instructions provided, as this medication may not be suitable for all patients.

Properly discard Urecholine when it is expired or no longer needed. Consult your healthcare provider for guidance on the appropriate disposal of this product.

Special care is required if Urecholine is given to patients receiving ganglion blocking compounds, as a critical fall in blood pressure may occur. Severe abdominal symptoms may appear before such a fall in blood pressure.

Long-term studies in animals have not been performed to evaluate the effects upon fertility, mutagenic, or carcinogenic potential of bethanechol chloride.

Urecholine falls under Pregnancy Category C. It is not known whether bethanechol chloride can cause fetal harm when administered to a pregnant woman or affect reproduction capacity. Therefore, it should be given to a pregnant woman only if clearly needed. It is also not known whether bethanechol chloride passes into breast milk, so nursing mothers should exercise caution when using this medication.

This is not an exhaustive list of warnings and precautions for Urecholine. If you have specific concerns or questions about using this medication, consult with your healthcare provider for personalized advice and guidance.